Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: N Engl J Med. 2019 Aug 1;381(5):432–443. doi: 10.1056/NEJMoa1817073

Figure 1. Enrollment, Randomization, and Follow-up.

Figure 1.

All 529 patients who had been enrolled in the trial were included in the intention-to-treat analysis. Of the 529 patients who underwent randomization, 31 (5.9%) were determined to have not met the eligibility criteria and were excluded from the analysis of eligible patients who started assigned therapy (see the Supplementary Appendix). The safety analysis included 510 patients who started the assigned protocol therapy. GFR denotes glomerular filtration rate.